Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
masoprocol | arachidonate 5-lipoxygenase | small molecule | NA | drugbank | Precancerous Conditions[MeSHID:D011230] Growth[MeSHID:D006128] Actinic keratosis[MeSHID:D055623] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of prostate[MeSHID:D011471] |
NA | approved,investigational | inhibitor |
masoprocol | erbb2 tyrosine kinase receptor | NA | Successful target | TTD , DGIDB | Precancerous Conditions[MeSHID:D011230] Growth[MeSHID:D006128] Actinic keratosis[MeSHID:D055623] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of prostate[MeSHID:D011471] |
0.43 | approved | unknown |
masoprocol | sex hormone-binding globulin | small molecule | NA | drugbank | Precancerous Conditions[MeSHID:D011230] Growth[MeSHID:D006128] Actinic keratosis[MeSHID:D055623] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of prostate[MeSHID:D011471] |
NA | approved,investigational | unknown |
click here to return to the previous page |